Skip to main content
BioNote, Inc. logo

BioNote, Inc. - Investor Relations & Filings

Listed IPO Dec 2022
Ticker · 377740 ISIN · KR7377740006 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2026-05-29 Director's Dealing
Country KR South Korea
Listing KO 377740 · 1 venue

Key figures FY2025

Period ended 2025-12-31 · KRW
Headline annual figures for BioNote, Inc., fiscal year 2025, reported in KRW, with the source filing for each figure.
Total Revenues KRW 118.32B per the Interim / Quarterly Report filed 2026-03-18
Net Income KRW -87.50B per the Interim / Quarterly Report filed 2026-03-18
Total Assets KRW 1555.89B per the Interim / Quarterly Report filed 2026-03-18
Total Equity KRW 1511.25B per the Interim / Quarterly Report filed 2026-03-18
Cash from Ops KRW 14.38B per the Interim / Quarterly Report filed 2026-03-18

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About BioNote, Inc.

https://www.bionote.com/

BioNote, Inc. is a company specializing in in-vitro diagnostics for the animal health industry. It develops, manufactures, and distributes a range of veterinary diagnostic products, including rapid test kits, ELISA kits, point-of-care (POC) analyzers, and biomarker tests. The company's portfolio is based on its research and development of core biological components like antigens and antibodies. Its products are designed for the detection and diagnosis of animal diseases, providing veterinarians with tools for immunochemical and quantitative analysis in clinical settings.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주특정증권등소유상황보고서', which translates to 'Report on Ownership of Specific Securities by Executives and Major Shareholders'. This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose changes in their shareholdings. This corresponds to the 'Director's Dealing' (DIRS) category, which covers insider trades and ownership reports by company directors and executives.
2026-05-29 Korean
기업지배구조보고서공시
Governance Information Classification · 100% confidence The document is a 'Corporate Governance Report' (기업지배구조보고서), which is a mandatory regulatory disclosure in South Korea detailing a company's governance structure, board composition, shareholder rights, and internal controls. It contains detailed tables regarding shareholder meeting results, board activities, and governance indicators. This document type is classified under 'Governance Information' (CGR) as it specifically details internal rules, board structure, and governance practices as defined in the provided categories.
2026-05-29 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 94% confidence The document is titled "분기보고서 (제 24 기) 2026년 01월 01일 ~ 2026년 03월 31일", which is the company’s formal quarterly report filed with the Financial Supervisory Service and Korea Exchange. It contains substantive financial data (capital changes, segment sales, production figures, business overview, etc.) for the first quarter of 2026, fulfilling the criteria for an Interim / Quarterly Report. Therefore, it should be classified as IR. Q1 2026
2026-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 92% confidence The document is a Korean ‘fair disclosure’ of preliminary consolidated financial results for Q1 (2026.01.01–2026.03.31), showing key metrics (revenue, operating profit, net profit) and noting its tentative nature pending audit. It is an initial announcement of periodical financial results (a typical quarterly earnings release), not a full interim report or the formal annual report. Hence it fits the Earnings Release category. Q1 2026
2026-05-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” which translates to a report on the holdings and changes of certain securities by officers and major shareholders. It details an officer (Kim Il Jung) and his acquisition of 160,000 shares via stock option exercise, including dates, quantities, price, and ownership percentages. This is exactly the type of insider transaction/holding disclosure by company directors or executives. Therefore, it fits the “Director's Dealing (DIRS)” category.
2026-04-21 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 98% confidence The document is a ‘최대주주등소유주식변동신고서’, i.e. a report on changes in the major shareholder’s share ownership. It provides detailed tables of shareholdings before and after the change, along with individual insider transactions. This matches the “Major Shareholding Notification” category (MRQ).
2026-04-21 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.